MktsMarkets

Biote Corp.
NASDAQ: BTMDKey statistics
BTMD News
Stories mentioning BTMD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 44,935 | 46,408 | 47,956 | 48,863 | 48,992 | 49,834 | 51,384 | 49,169 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 27,787 | 24,744 | 26,151 | 24,223 | 26,692 | 33,028 | 23,922 | 27,575 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 3,166 | 6,829 | 8,267 | 10,765 | 9,690 | 2,767 | 12,184 | 6,233 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (5.00) | (2.00) | (3.00) | (6.00) | (18.00) | (2.00) | ||
| Pretax Income | 3,338 | 5,603 | 8,451 | 6,075 | 17,455 | (1,220) | 15,855 | (10,295) |
| Tax Provision | 662.00 | 2,986 | (765.00) | 2,150 | 1,616 | (4,703) | 3,198 | 73.00 |
| Net Income (Loss) | 2,277 | 1,954 | 8,188 | 3,185 | 13,718 | 3,703 | 10,702 | (7,087) |
| Earnings Per Share (Basic) | 0.07 | 0.06 | 0.26 | 0.10 | 0.44 | 0.11 | 0.34 | (0.21) |
| Earnings Per Share (Diluted) | 0.06 | 0.05 | 0.22 | 0.10 | 0.37 | 0.11 | 0.33 | (0.21) |
| Weighted Average Shares Outstanding (Basic) | 30,646 | 31,283 | 31,332 | 31,625 | 31,486 | 34,271 | 31,045 | 33,072 |
| Weighted Average Shares Outstanding (Diluted) | 35,995 | 36,667 | 36,709 | 31,743 | 36,953 | 34,271 | 32,261 | 33,072 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BTMD
Biote Corp. (NASDAQ: BTMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol BTMD. It last traded at $1.11 (Oct 30, 2026, 4:00 PM ET), down 5.1% on the day. That gives Biote a market capitalisation of $39.9M and a price-to-earnings ratio of 6.8.
Over the past 52 weeks BTMD has traded between $1.00 and $2.98.
Revenue for the quarter ended Mar 31, 2026 was $44.9M; net income $2.3M. Revenue was down 8.3% from $49.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $44.9M | $2.3M | 5.1% |
| Dec 31, 2025 | $46.4M | $2.0M | 4.2% |
| Sep 30, 2025 | $48.0M | $8.2M | 17.1% |
| Jun 30, 2025 | $48.9M | $3.2M | 6.5% |
From Biote’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…